# Popular, Inc.: financial statements, quarterly

BPOP · Nasdaq · CIK 763901 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bpop.md) · [Financials](/companies/bpop/financials.md) · [Filings](/companies/bpop/filings.md) · [Insiders](/companies/bpop/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bpop/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [37.4](/filings/0001193125-25-117624.md) | not reported | not reported | not reported | [39.1](/filings/0001193125-26-214600.md) | not reported | not reported | not reported | [38.8](/filings/0001193125-26-214600.md) | not reported |
| Interest expense | $m | [311](/filings/0001193125-24-255718.md) | [333 d](/filings/0001193125-26-085756.md) | [343](/filings/0001193125-25-117624.md) | [354](/filings/0001193125-25-177928.md) | [365](/filings/0001193125-25-274035.md) | [329 d](/filings/0001193125-26-085756.md) | [311](/filings/0001193125-26-214600.md) | [312](/filings/0000763901-26-000019.md) | [320](/filings/0001193125-25-274035.md) | [298 d](/filings/0001193125-26-085756.md) | [277](/filings/0001193125-26-214600.md) | [288](/filings/0000763901-26-000019.md) |
| Income tax | $m | [45.9](/filings/0001193125-24-255718.md) | [(1.5) d](/filings/0001193125-26-085756.md) | [55.6](/filings/0001193125-25-117624.md) | [40.5](/filings/0001193125-25-177928.md) | [42.5](/filings/0001193125-25-274035.md) | [43.9 d](/filings/0001193125-26-085756.md) | [45.1](/filings/0001193125-26-214600.md) | [47.9](/filings/0000763901-26-000019.md) | [36.0](/filings/0001193125-25-274035.md) | [44.7 d](/filings/0001193125-26-085756.md) | [46.9](/filings/0001193125-26-214600.md) | [45.7](/filings/0000763901-26-000019.md) |
| Net income | $m | [137](/filings/0001193125-24-255718.md) | [94.6 d](/filings/0001193125-26-085756.md) | [103](/filings/0001193125-25-117624.md) | [178](/filings/0001193125-25-177928.md) | [155](/filings/0001193125-25-274035.md) | [178 d](/filings/0001193125-26-085756.md) | [178](/filings/0001193125-26-214600.md) | [210](/filings/0000763901-26-000019.md) | [211](/filings/0001193125-25-274035.md) | [234 d](/filings/0001193125-26-085756.md) | [246](/filings/0001193125-26-214600.md) | [278](/filings/0000763901-26-000019.md) |
| Diluted EPS | $ per share | [1.90](/filings/0001193125-24-255718.md) | not reported | [1.43](/filings/0001193125-25-117624.md) | [2.46](/filings/0001193125-25-177928.md) | [2.16](/filings/0001193125-25-274035.md) | not reported | [2.56](/filings/0001193125-26-214600.md) | [3.09](/filings/0000763901-26-000019.md) | [3.14](/filings/0001193125-25-274035.md) | not reported | [3.78](/filings/0001193125-26-214600.md) | [4.35](/filings/0000763901-26-000019.md) |
| Basic EPS | $ per share | [1.90](/filings/0001193125-24-255718.md) | not reported | [1.43](/filings/0001193125-25-117624.md) | [2.47](/filings/0001193125-25-177928.md) | [2.16](/filings/0001193125-25-274035.md) | not reported | [2.56](/filings/0001193125-26-214600.md) | [3.09](/filings/0000763901-26-000019.md) | [3.15](/filings/0001193125-25-274035.md) | not reported | [3.78](/filings/0001193125-26-214600.md) | [4.35](/filings/0000763901-26-000019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [69.7](/filings/0001193125-24-255718.md) | [70.8](/filings/0001193125-26-085756.md) | [70.9](/filings/0001193125-25-117624.md) | [72.8](/filings/0001193125-25-177928.md) | [71.3](/filings/0001193125-25-274035.md) | [73.0](/filings/0001193125-26-085756.md) | [74.0](/filings/0001193125-26-214600.md) | [76.1](/filings/0000763901-26-000019.md) | [75.1](/filings/0001193125-25-274035.md) | [75.3](/filings/0000763901-26-000019.md) | [76.1](/filings/0001193125-26-214600.md) | [79.0](/filings/0000763901-26-000019.md) |
| Total liabilities | $bn | [65.3](/filings/0001193125-23-274342.md) | [65.6](/filings/0001193125-25-043848.md) | [65.8](/filings/0001193125-24-136053.md) | [67.5](/filings/0001193125-24-197914.md) | [65.5](/filings/0001193125-24-255718.md) | [67.4](/filings/0001193125-26-085756.md) | [68.2](/filings/0001193125-25-117624.md) | [70.1](/filings/0001193125-25-177928.md) | [69.0](/filings/0001193125-25-274035.md) | [69.1](/filings/0000763901-26-000019.md) | [69.8](/filings/0001193125-26-214600.md) | [72.5](/filings/0000763901-26-000019.md) |
| Shareholders' equity | $bn | [4.5](/filings/0001193125-24-255718.md) | [5.1](/filings/0001193125-26-085756.md) | [5.2](/filings/0001193125-25-177928.md) | [5.4](/filings/0001193125-25-274035.md) | [5.8](/filings/0001193125-25-274035.md) | [5.6](/filings/0000763901-26-000019.md) | [5.8](/filings/0000763901-26-000019.md) | [6.0](/filings/0000763901-26-000019.md) | [6.1](/filings/0001193125-25-274035.md) | [6.2](/filings/0000763901-26-000019.md) | [6.3](/filings/0000763901-26-000019.md) | [6.4](/filings/0000763901-26-000019.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0001193125-24-255718.md) | [214 d](/filings/0001193125-26-085756.md) | [162](/filings/0001193125-25-117624.md) | [80.4 d](/filings/0001193125-25-177928.md) | [233 d](/filings/0001193125-25-274035.md) | [199 d](/filings/0001193125-26-085756.md) | [172](/filings/0001193125-26-214600.md) | [243 d](/filings/0000763901-26-000019.md) | [195 d](/filings/0001193125-25-274035.md) | [268 d](/filings/0001193125-26-085756.md) | [192](/filings/0001193125-26-214600.md) | [347 d](/filings/0000763901-26-000019.md) |
| Capital expenditure | $m | [48.3 d](/filings/0001193125-24-255718.md) | [74.4 d](/filings/0001193125-26-085756.md) | [53.9](/filings/0001193125-25-117624.md) | [41.5 d](/filings/0001193125-25-177928.md) | [57.7 d](/filings/0001193125-25-274035.md) | [60.3 d](/filings/0001193125-26-085756.md) | [51.5](/filings/0001193125-26-214600.md) | [44.7 d](/filings/0000763901-26-000019.md) | [53.9 d](/filings/0001193125-25-274035.md) | [47.4 d](/filings/0001193125-26-085756.md) | [36.7](/filings/0001193125-26-214600.md) | [57.1 d](/filings/0000763901-26-000019.md) |
| Dividends paid | $m | [39.9 d](/filings/0001193125-24-255718.md) | [40.1 d](/filings/0001193125-26-085756.md) | [45.0](/filings/0001193125-25-117624.md) | [45.2 d](/filings/0001193125-25-177928.md) | [45.3 d](/filings/0001193125-25-274035.md) | [45.0 d](/filings/0001193125-26-085756.md) | [49.9](/filings/0001193125-26-214600.md) | [48.8 d](/filings/0000763901-26-000019.md) | [48.2 d](/filings/0001193125-25-274035.md) | [50.7 d](/filings/0001193125-26-085756.md) | [49.9](/filings/0001193125-26-214600.md) | [49.0 d](/filings/0000763901-26-000019.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [(59.1)](/filings/0001193125-25-274035.md) | [283 d](/filings/0001193125-25-043848.md) | not reported | not reported | [(120)](/filings/0001193125-25-274035.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [74.1](/filings/0001193125-23-274342.md) | [71.6](/filings/0001193125-24-136053.md) | [71.7](/filings/0001193125-24-197914.md) | [71.8](/filings/0001193125-24-255718.md) | [72.0](/filings/0001193125-25-117624.md) | [72.0](/filings/0001193125-25-177928.md) | [71.8](/filings/0001193125-25-274035.md) | [69.3](/filings/0001193125-26-214600.md) | [68.1](/filings/0000763901-26-000019.md) | [67.1](/filings/0001193125-25-274035.md) | [64.9](/filings/0001193125-26-214600.md) | [63.9](/filings/0000763901-26-000019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 63,778,501 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0000763901-26-000019.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.